International Patent: LONG-ACTING DOPAMINE RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA OR BIPOLAR DISORDER

GENEVA, Sept. 18 -- AXCENTRA PHARMA INC. filed a patent application (US2026/017608) for “LONG-ACTING DOPAMINE RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA OR BIPOLAR DISORDER”. With publication no. WO/2026/187850, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/495

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....